Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

The new topical growth hormone formula has high skin penetration and bioavailability.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Polycystic ovary syndrome is a common hormonal disorder in women that affects health and fertility.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Adipocytes have diverse roles in energy storage, protection, tissue repair, and influence health and disease.

Metformin effectively reduces hormone levels in women with PCOS.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

An artificial lipid barrier can restore hair growth in cases of SCD1 deficiency.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Early hair loss may predict heart disease.

Lifestyle changes like diet and exercise are crucial for managing PCOS.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

New near-infrared OLED emitters are more efficient, especially platinum(II) complexes, and have promising applications like hair growth treatment.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Male hormones promote hair cell growth by using a growth factor from nearby skin cells.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Early hair loss may indicate risk of insulin resistance.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

IGF-1 can boost hair growth by promoting cell growth and preventing cell death.

Eating a high-glycemic diet may worsen acne by increasing certain protein levels and expressions in the skin.